The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT05218616 · UNKNOWN
Trial details
- NCT number
- NCT05218616
- Sponsor
- JLLC NatiVita
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2022-03-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.